86 related articles for article (PubMed ID: 3710289)
1. Lacto-N-fucopentaose III activity in the serum of patients with ovarian carcinoma.
Cox CJ; Freedman RG; Fritsche HA
Gynecol Obstet Invest; 1986; 21(3):164-8. PubMed ID: 3710289
[TBL] [Abstract][Full Text] [Related]
2. [Clinical usefulness of the combination assay of CA 125, SLX, and CA 72-4 in patients with ovarian cancer].
Kobayashi H; Kawashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1731-5. PubMed ID: 2574209
[TBL] [Abstract][Full Text] [Related]
3. The sebaceous gland antigen defined by the OM-1 monoclonal antibody is expressed at high density on the surface of ovarian carcinoma cells.
de Kretser TA; Thorne HJ; Jacobs DJ; Jose DG
Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1019-35. PubMed ID: 2998800
[TBL] [Abstract][Full Text] [Related]
4. Increased sensitivity in detecting tumor-associated antigens in sera of patients with colorectal carcinoma.
Herlyn M; Sears HF; Verrill H; Koprowski H
J Immunol Methods; 1984 Dec; 75(1):15-21. PubMed ID: 6512262
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluations of the tumor marker sialyl SSEA-1 antigen for clinical gynecological disease.
Iwanari O; Miyako J; Date Y; Nakayama S; Kijima S; Moriyama M; Karino K; Endoh J; Kitao M
Gynecol Obstet Invest; 1990; 29(3):214-8. PubMed ID: 1972688
[TBL] [Abstract][Full Text] [Related]
6. Antigen CA125 in tumor tissue and serum from patients with adenocarcinoma of the ovary.
Maughan TS; Fish RG; Shelley M; Jasani B; Williams GT; Adams M
Gynecol Oncol; 1988 Jul; 30(3):342-6. PubMed ID: 2839394
[TBL] [Abstract][Full Text] [Related]
7. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.
Bast RC; Klug TL; St John E; Jenison E; Niloff JM; Lazarus H; Berkowitz RS; Leavitt T; Griffiths CT; Parker L; Zurawski VR; Knapp RC
N Engl J Med; 1983 Oct; 309(15):883-7. PubMed ID: 6310399
[TBL] [Abstract][Full Text] [Related]
8. Clinical use of CA 125 and its combination assay with other tumor marker in patients with ovarian carcinoma.
Negishi Y; Furukawa T; Oka T; Sakamoto M; Hirata T; Okabe K; Matayoshi K; Akiya K; Soma H
Gynecol Obstet Invest; 1987; 23(3):200-7. PubMed ID: 3474196
[TBL] [Abstract][Full Text] [Related]
9. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
Negishi Y; Iwabuchi H; Sakunaga H; Sakamoto M; Okabe K; Sato H; Asano G
Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
[TBL] [Abstract][Full Text] [Related]
10. Relationship of serum CA125 and lipid-associated sialic acid tumor-associated antigen levels to the disease status of patients with gynecologic malignancies.
Stratton JA; Rettenmaier MA; Phillips HB; Herabutya S; DiSaia PJ
Obstet Gynecol; 1988 Jan; 71(1):20-6. PubMed ID: 2827081
[TBL] [Abstract][Full Text] [Related]
11. My-1, the human myeloid-specific antigen detected by mouse monoclonal antibodies, is a sugar sequence found in lacto-N-fucopentaose III.
Huang LC; Civin CI; Magnani JL; Shaper JH; Ginsburg V
Blood; 1983 May; 61(5):1020-3. PubMed ID: 6187397
[No Abstract] [Full Text] [Related]
12. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcinoembryonic antigen reactivity.
Thor A; Muraro R; Gorstein F; Ohuchi N; Viglione M; Szpak CA; Johnston WW; Schlom J
Cancer Res; 1987 Jan; 47(2):505-12. PubMed ID: 2431771
[TBL] [Abstract][Full Text] [Related]
13. [Immunodiagnosis of ovarian cancer].
Zhang J; Cao Z; Sun Z; Sun Z
Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(3):325-8. PubMed ID: 1748422
[TBL] [Abstract][Full Text] [Related]
14. A longitudinal study of antigen expression in epithelial ovarian cancer.
Rubin SC; Finstad CL; Hoskins WJ; Federici MG; Lloyd KO; Lewis JL
Gynecol Oncol; 1989 Sep; 34(3):389-94. PubMed ID: 2767530
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of circulating serum sialyl Tn antigen levels in patients with epithelial ovarian cancer.
Kobayashi H; Terao T; Kawashima Y
J Clin Oncol; 1991 Jun; 9(6):983-7. PubMed ID: 1851822
[TBL] [Abstract][Full Text] [Related]
16. [Serum level of the tumor marker CA 125 in ovarian pathology].
Bagni B; Pansini FS; Feggi LM; Prandini N; Mollica G
Radiol Med; 1987 Nov; 74(5):448-50. PubMed ID: 3479814
[TBL] [Abstract][Full Text] [Related]
17. The role of CA 125 and conventional examinations in diagnosing progressive carcinoma of the ovary.
van der Burg ME; Lammes FB; Verweij J
Surg Gynecol Obstet; 1993 Apr; 176(4):310-4. PubMed ID: 8460404
[TBL] [Abstract][Full Text] [Related]
18. [Distribution and diagnostic role of COTA in mucinous ovarian tumors].
Shi ZL
Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):191-2. PubMed ID: 2612330
[TBL] [Abstract][Full Text] [Related]
19. The antitumor monoclonal antibody MOv2 recognizes the Lewis A hapten.
Leoni F; Magnani JL; Miotti S; Canevari S; Pasquali M; Sonnino S; Colnaghi MI
Hybridoma; 1988 Apr; 7(2):129-39. PubMed ID: 3372000
[TBL] [Abstract][Full Text] [Related]
20. Total lactate dehydrogenase and its isozymes in serum from patients with primary carcinoma of the ovary.
Kikuchi Y; Hisano A; Kuki E; Hirata J; Nagata I
Gynecol Obstet Invest; 1991; 31(3):161-5. PubMed ID: 2071055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
